Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer

BACKGROUND: Advances in cancer immunotherapy have generated encouraging results in multiple malignancies refractory to standard chemotherapies. As the use of immune checkpoint inhibitors (ICI) proliferates, the incidence of autoimmune side effects associated with these agents, termed immune related...

Descripción completa

Detalles Bibliográficos
Autores principales: Godwin, James Luke, Jaggi, Shuchie, Sirisena, Imali, Sharda, Pankaj, Rao, Ajay D., Mehra, Ranee, Veloski, Colleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433051/
https://www.ncbi.nlm.nih.gov/pubmed/28515940
http://dx.doi.org/10.1186/s40425-017-0245-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433051/
https://www.ncbi.nlm.nih.gov/pubmed/28515940
http://dx.doi.org/10.1186/s40425-017-0245-2

Ejemplares similares